These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 36398426)
21. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449 [TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase. Avraham HK; Lee TH; Koh Y; Kim TA; Jiang S; Sussman M; Samarel AM; Avraham S J Biol Chem; 2003 Sep; 278(38):36661-8. PubMed ID: 12844492 [TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020 [TBL] [Abstract][Full Text] [Related]
24. Structural determinants of growth factor binding and specificity by VEGF receptor 2. Leppänen VM; Prota AE; Jeltsch M; Anisimov A; Kalkkinen N; Strandin T; Lankinen H; Goldman A; Ballmer-Hofer K; Alitalo K Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2425-30. PubMed ID: 20145116 [TBL] [Abstract][Full Text] [Related]
25. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis. Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666 [TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. Rousseau S; Houle F; Kotanides H; Witte L; Waltenberger J; Landry J; Huot J J Biol Chem; 2000 Apr; 275(14):10661-72. PubMed ID: 10744763 [TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src. Lee YH; Kayyali US; Sousa AM; Rajan T; Lechleider RJ; Day RM Am J Respir Cell Mol Biol; 2007 Oct; 37(4):485-93. PubMed ID: 17585111 [TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]. Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440 [TBL] [Abstract][Full Text] [Related]
29. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. Holmqvist K; Cross MJ; Rolny C; Hägerkvist R; Rahimi N; Matsumoto T; Claesson-Welsh L; Welsh M J Biol Chem; 2004 May; 279(21):22267-75. PubMed ID: 15026417 [TBL] [Abstract][Full Text] [Related]
30. Differential expression of VEGF ligands and receptors in prostate cancer. Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Takahashi N; Seko Y; Noiri E; Tobe K; Kadowaki T; Sabe H; Yazaki Y Circ Res; 1999 May; 84(10):1194-202. PubMed ID: 10347094 [TBL] [Abstract][Full Text] [Related]
32. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Yonemura Y; Fushida S; Bando E; Kinoshita K; Miwa K; Endo Y; Sugiyama K; Partanen T; Yamamoto H; Sasaki T Eur J Cancer; 2001 May; 37(7):918-23. PubMed ID: 11313181 [TBL] [Abstract][Full Text] [Related]
33. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004 [TBL] [Abstract][Full Text] [Related]
34. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression. Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182 [TBL] [Abstract][Full Text] [Related]
35. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204 [TBL] [Abstract][Full Text] [Related]
36. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis. Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667 [TBL] [Abstract][Full Text] [Related]
37. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Park HR; Min K; Kim HS; Jung WW; Park YK Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723 [TBL] [Abstract][Full Text] [Related]
38. Molecular controls of lymphatic VEGFR3 signaling. Deng Y; Zhang X; Simons M Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775 [TBL] [Abstract][Full Text] [Related]
39. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Favier B; Alam A; Barron P; Bonnin J; Laboudie P; Fons P; Mandron M; Herault JP; Neufeld G; Savi P; Herbert JM; Bono F Blood; 2006 Aug; 108(4):1243-50. PubMed ID: 16621967 [TBL] [Abstract][Full Text] [Related]
40. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway. Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]